Bipolar Disorder Trial, Recruiting NCT05427123 Sponsor: University of California, Los Angeles Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT05427123
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Young people between 9 and 19 years old
  • Young people who have been diagnosed with Bipolar Disorder (Type I, Type II, or Other Specified) or Cyclothymic Disorder by the study team during a screening interview
  • Young people who can read and communicate in English well enough to take part in treatment and assessments designed for ages 9 and up (with help as needed)
  • Young people who have a caregiver able to regularly take part in assessments and treatment sessions
  • A participating caregiver who can read and communicate in English for the purposes of consenting, assessments, and treatment — unless translation services in another language are regularly available through the trial

Who may not be able to join:

  • Young people who have a diagnosis of Autism Spectrum Disorder
  • Young people who have a diagnosis of substance or alcohol abuse that has caused significant problems within the past 3 months
  • Young people who have a medical or psychiatric condition that is life-threatening or requires immediate hospitalisation or emergency treatment
  • Cases where there is recent evidence of sexual or physical abuse of the young person by a caregiver who is legally responsible for them
  • Cases where there is recent evidence of violence between the caregivers who are responsible for the young person's care

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David J Miklowitz, PhD, University of California, Los Angeles

Phone: (310) 267-2659

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE) Psychiatric Status Ratings; Change in Children's Affective Lability Scale (CALS), Child and Parent Report forms; Change in Conflict Behavior Questionnaire (CBQ) scores, Child and Parent Report forms; Kiddo-KINDL Quality of Life Questionnaire for Children, Child and Parent Reports forms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov